171 related articles for article (PubMed ID: 16002712)
1. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses.
Lazarevic V; Nolt D; Flynn JL
J Immunol; 2005 Jul; 175(2):1107-17. PubMed ID: 16002712
[TBL] [Abstract][Full Text] [Related]
2. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.
Lazarevic V; Yankura DJ; DiVito SJ; Flynn JL
Infect Immun; 2005 May; 73(5):2910-22. PubMed ID: 15845497
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T cell-dependent IFN-γ production by CD8+ effector T cells in Mycobacterium tuberculosis infection.
Bold TD; Ernst JD
J Immunol; 2012 Sep; 189(5):2530-6. PubMed ID: 22837486
[TBL] [Abstract][Full Text] [Related]
4. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection.
Serbina NV; Lazarevic V; Flynn JL
J Immunol; 2001 Dec; 167(12):6991-7000. PubMed ID: 11739519
[TBL] [Abstract][Full Text] [Related]
5. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
Tully G; Kortsik C; Höhn H; Zehbe I; Hitzler WE; Neukirch C; Freitag K; Kayser K; Maeurer MJ
J Immunol; 2005 Feb; 174(4):2174-84. PubMed ID: 15699149
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
[TBL] [Abstract][Full Text] [Related]
7. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.
Hessmann M; Rausch A; Rückerl D; Adams PS; Simon M; Gilfillan S; Colonna M; Ehlers S; Hölscher C
Immunobiology; 2011 May; 216(5):639-47. PubMed ID: 21122940
[TBL] [Abstract][Full Text] [Related]
8. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
[TBL] [Abstract][Full Text] [Related]
9. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.
Ngai P; McCormick S; Small C; Zhang X; Zganiacz A; Aoki N; Xing Z
Infect Immun; 2007 May; 75(5):2244-52. PubMed ID: 17307945
[TBL] [Abstract][Full Text] [Related]
10. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
[TBL] [Abstract][Full Text] [Related]
11. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens.
Caccamo N; Meraviglia S; La Mendola C; Guggino G; Dieli F; Salerno A
J Immunol; 2006 Aug; 177(3):1780-5. PubMed ID: 16849488
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection.
Green AM; Difazio R; Flynn JL
J Immunol; 2013 Jan; 190(1):270-7. PubMed ID: 23233724
[TBL] [Abstract][Full Text] [Related]
13. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients.
Gerosa F; Nisii C; Righetti S; Micciolo R; Marchesini M; Cazzadori A; Trinchieri G
Clin Immunol; 1999 Sep; 92(3):224-34. PubMed ID: 10479527
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection.
Jeong YH; Jeon BY; Gu SH; Cho SN; Shin SJ; Chang J; Ha SJ
Infect Immun; 2014 Jan; 82(1):132-9. PubMed ID: 24126533
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.
Woodworth JS; Wu Y; Behar SM
J Immunol; 2008 Dec; 181(12):8595-603. PubMed ID: 19050279
[TBL] [Abstract][Full Text] [Related]
17. T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents.
Seshadri C; Lin L; Scriba TJ; Peterson G; Freidrich D; Frahm N; DeRosa SC; Moody DB; Prandi J; Gilleron M; Mahomed H; Jiang W; Finak G; Hanekom WA; Gottardo R; McElrath MJ; Hawn TR
J Immunol; 2015 Nov; 195(10):4595-603. PubMed ID: 26466957
[TBL] [Abstract][Full Text] [Related]
18. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
[TBL] [Abstract][Full Text] [Related]
19. Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern.
Höhn H; Kortsik C; Nilges K; Necker A; Freitag K; Tully G; Neukirch C; Maeurer MJ
Immunology; 2001 Nov; 104(3):278-88. PubMed ID: 11722642
[TBL] [Abstract][Full Text] [Related]
20. Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.
Flórido M; Pillay R; Gillis CM; Xia Y; Turner SJ; Triccas JA; Stambas J; Britton WJ
Eur J Immunol; 2015 Mar; 45(3):780-93. PubMed ID: 25430701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
